TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Polycystic ovary syndrome (PCOS)
Key Statistics
- 10–15% — Prevalence of PCOS in general population
- 2 of 3 — Rotterdam criteria required for diagnosis
- 80–90% — Anovulatory infertility due to PCOS
Don't-miss facts
-
Diagnosis = 2 of 3 Rotterdam criteria (hyperandrogenism, oligo/anovulation, PCO on scan) after excluding other causes
-
PCO on ultrasound: ≥12 follicles (2–9mm) and/or volume >10cm³
-
CC dosing: 50→100mg days 2–5; multiple pregnancy risk ~10%; day-8 LH guides switching if persistently ↑
-
Letrozole beats CC for live birth (OR 1.64) with less multiple pregnancy (OR 0.38) but is not UK-licensed for this indication
-
Gonadotrophin hCG trigger at follicle ≥17mm; withhold if ≥2 follicles >14mm
-
LOD: 4 points/ovary, 4 sec, 40W – adhesion rate 10–20% (vs 100% wedge resection)
-
Endometrium must be shed at least every 3 months; amenorrhoeic + endometrium >10mm → induce bleed + rescan/biopsy
-
Defer fertility treatment until BMI <35 (aim <30 if younger/good reserve); bariatric referral if BMI >40 (or >35 with comorbidity)
First- vs second-line ovulation induction
First line: clomifene citrate (50–100mg) CC-resistant: gonadotrophins or LOD → IVF
Abbreviation Key
- ESHRE — European Society for Human Reproduction and
- CAH — congenital adrenal hyperplasia Embryology
- HRQoL — health-related quality of life
- ASRM — American Society of Reproductive Medicine
- CC — clomifene citrate
- LH — luteinising hormone
- OHSS — ovarian hyperstimulation syndrome
- FSH — follicle stimulating hormone
- LOD — laparoscopic ovarian diathermy
- SHBG — sex hormone binding globulin
- rFSH — recombinant follicle stimulating hormone
- AMH — anti-müllerian hormone
- hCG — human chorionic gonadotropin
- GTT — glucose tolerance test
- IVF — in vitro fertilisation
- IGT — impaired glucose tolerance
- WHO — World Health Organization
- HbA1c — glycosylated haemoglobin
- OR — odds ratio
- BMI — body mass index
- CI — confidence interval
Source: Balen AH. Polycystic ovary syndrome (PCOS). The Obstetrician & Gynaecologist 2017;19:119–129. doi:10.1111/tog.12345
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).